Verona Pharma plc
Hedge Funds Holdings
Last updated:
Verona Pharma plc‘s stocks are currently a part of 46 hedge funds’ portfolios, which represents 3.83% of the total amount of its stocks outstanding. This makes up a total of 20.26M shares of Verona Pharma plc. Compared to the previous quarter, the number fell by -62.78% or -34.18M shares fewer. As for the holding position changes, 45.65% (21) of current hedge fund investors increased the number of shares held, 19.57% (9) of current holders sold a part of the shares held, and 15.22% (7) closed the holdings completely. 10 hedge funds are new holders of Verona Pharma plc stock in Q1 2023, it is 21.74% of total holders.
Hedge funds holding Verona Pharma (Q2 2018 – Q1 2023)
| Q2 2018 | 13 |
|---|---|
| Q3 2018 | 14 |
| Q4 2018 | 17 |
| Q1 2019 | 17 |
| Q2 2019 | 17 |
| Q3 2019 | 13 |
| Q4 2019 | 14 |
| Q1 2020 | 14 |
| Q2 2020 | 18 |
| Q3 2020 | 28 |
| Q4 2020 | 34 |
| Q1 2021 | 35 |
| Q2 2021 | 34 |
| Q3 2021 | 37 |
| Q4 2021 | 42 |
| Q1 2022 | 37 |
| Q2 2022 | 36 |
| Q3 2022 | 65 |
| Q4 2022 | 86 |
| Q1 2023 | 46 |
Hedge funds changes in Verona Pharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 1 | 3 | 2 | 6 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 0 | 2 | 1 | 9 |
| Q4 2018 | 4 | 1 | 2 | 1 | 9 |
| Q1 2019 | 3 | 2 | 1 | 2 | 9 |
| Q2 2019 | 1 | 0 | 4 | 1 | 11 |
| Q3 2019 | 0 | 2 | 2 | 4 | 5 |
| Q4 2019 | 2 | 3 | 0 | 1 | 8 |
| Q1 2020 | 3 | 1 | 4 | 3 | 3 |
| Q2 2020 | 5 | 2 | 0 | 1 | 10 |
| Q3 2020 | 15 | 8 | 3 | 5 | -3 |
| Q4 2020 | 10 | 7 | 4 | 3 | 10 |
| Q1 2021 | 7 | 7 | 9 | 6 | 6 |
| Q2 2021 | 5 | 5 | 5 | 6 | 13 |
| Q3 2021 | 8 | 7 | 4 | 5 | 13 |
| Q4 2021 | 10 | 6 | 7 | 5 | 14 |
| Q1 2022 | 3 | 9 | 4 | 8 | 13 |
| Q2 2022 | 7 | 6 | 4 | 8 | 11 |
| Q3 2022 | 36 | 14 | 7 | 6 | 2 |
| Q4 2022 | 32 | 25 | 23 | 9 | -3 |
| Q1 2023 | 10 | 21 | 9 | 7 | -1 |
Hedge funds changes in Verona Pharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 85,000 | 104,000 |
| Q1 2021 | 0 | 100,000 |
| Q2 2021 | 4,000 | 35,000 |
| Q3 2021 | 4,000 | 33,000 |
| Q4 2021 | 12,000 | 409,000 |
| Q1 2022 | 79,000 | 0 |
| Q2 2022 | 388,000 | 0 |
| Q3 2022 | 5,566,000 | 1,893,000 |
| Q4 2022 | 29,821,943 | 6,296,145 |
| Q1 2023 | 616,571,000 | 4,154,000 |